Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 15/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3721035 | 0.83 | L3MBTL1 (0.46) | PDK2MEN1MAPTKMT2AL3MBTL1 | |
| SCHEMBL29377775 | 0.83 | L3MBTL1 (0.46) | PDK2MEN1MAPTKMT2AL3MBTL1 | |
| SCHEMBL9898232 | 0.80 | MEN1 (0.39) | PDK2MEN1MAPTKMT2AL3MBTL1 | |
| SCHEMBL5502936 | 0.78 | MEN1 (0.38) | PDK2MEN1MAPTKMT2AL3MBTL1 | |
| SCHEMBL6353229 | 0.74 | MMP12 (0.38) | PDK2MEN1MAPTKMT2AL3MBTL1 | |
| SCHEMBL28783767 | 0.74 | MEN1 (0.42) | PDK2MEN1MAPTKMT2AL3MBTL1 | |
| SCHEMBL9898757 | 0.73 | LPL (0.41) | MEN1MAPTKMT2AL3MBTL1ALDH1A1 | |
| SCHEMBL27801466 | 0.73 | MEN1 (0.36) | PDK2MEN1MAPTKMT2AL3MBTL1 | |
| SCHEMBL5501660 | 0.73 | MEN1 (0.34) | MEN1MAPTKMT2AL3MBTL1 | |
| SCHEMBL9898305 | 0.72 | MEN1 (0.39) | MEN1MAPTKMT2AL3MBTL1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080197346-A1 | Nitrogen-containing heteroaromatic ligand-transition metal complexes, buffer layer comprising the complexes and organic thin film transistor comprising the buffer layer | SAMSUNG ELECTRONICS CO., LTD. | 2008-08-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080197346-A1 | Nitrogen-containing heteroaromatic ligand-transition metal complexes, buffer layer comprising the complexes and organic thin film transistor comprising the buffer layer | TTN, SLCO4C1, SLC6A19 | PDK2 4486/4885MEN1 371/4885MAPT 400/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.